@ARTICLE{
author={Domine Gomez Manuel|,Csoszi Tibor|,Jaal Jana|,Kudaba Iveta|,Nikolov Krassimir|,Radosavljevic Davorin Z|,Xiao Jie|,Horton Janet K|,Malik Rajesh K|,Subramanian Janakiraman|},
year={2021},
title={Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer},
journal={INTERNATIONAL JOURNAL OF CANCER},
volume={149},
number={7},
pages={1463-1472},
document_type={Article},
} 

@ARTICLE{
author={Hart Lowell L|,Ferrarotto Renata|,Andric Zoran G|0000-0002-1495-2729,Beck Thaddeus J|,Subramanian Janakiraman|,Radosavljevic Davorin Z|,Zaric Bojan|0000-0003-3215-8390,Hanna Wahid T|,Aljumaily Raid|,Owonikoko Taofeek K|,Verhoeven Didier|,Xiao Jie|,Morris Shannon R|,Antal Joyce M|,Hussein Maen A|},
year={2021},
title={Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study},
journal={ADVANCES IN THERAPY},
volume={38},
number={1},
pages={350-365},
document_type={Article},
}